"adverse events" trang 6 - tải miễn phí từ tailieunhanh
Case report: Reinitiating pembrolizumab treatment after small bowel perforation

Case report: Reinitiating pembrolizumab treatment after small bowel perforation
9    87    0
Acral vascular necrosis associated with immune-check point inhibitors: Case report with literature review

Acral vascular necrosis associated with immune-check point inhibitors: Case report with literature review
6    52    0
Evaluation of disability in patients exposed to fluoroquinolones

Evaluation of disability in patients exposed to fluoroquinolones
11    90    0
Neuromyelitis optica spectrum disorder secondary to treatment with anti-PD-1 antibody nivolumab: The first report

Neuromyelitis optica spectrum disorder secondary to treatment with anti-PD-1 antibody nivolumab: The first report
4    38    1
A remarkable response to pazopanib, despite recurrent liver toxicity, in a patient with a high grade endometrial stromal sarcoma, a case report

A remarkable response to pazopanib, despite recurrent liver toxicity, in a patient with a high grade endometrial stromal sarcoma, a case report
6    35    1
High-dose thiotepa-related neurotoxicity and the role of tramadol in children

High-dose thiotepa-related neurotoxicity and the role of tramadol in children
9    49    1
Re-challenging immune checkpoint inhibitor in a patient with advanced nonsmall cell lung cancer: A case report

Re-challenging immune checkpoint inhibitor in a patient with advanced nonsmall cell lung cancer: A case report
4    51    1
Preventing adverse events of chemotherapy by educating patients about the nocebo effect (RENNO study) – study protocol of a randomized controlled trial with gastrointestinal cancer patients

Preventing adverse events of chemotherapy by educating patients about the nocebo effect (RENNO study) – study protocol of a randomized controlled trial with gastrointestinal cancer patients
8    60    1
Impact on clinical practice of the implementation of guidelines for the toxicity management of targeted therapies in kidney cancer: The protect-2 study

Impact on clinical practice of the implementation of guidelines for the toxicity management of targeted therapies in kidney cancer: The protect-2 study
10    57    1
Comparison of weekly administration of cisplatin versus three courses of cisplatin 100 mg/m2 for definitive radiochemotherapy of locally advanced head-and-neck cancers

Comparison of weekly administration of cisplatin versus three courses of cisplatin 100 mg/m2 for definitive radiochemotherapy of locally advanced head-and-neck cancers
8    45    1
Cytokine serum levels during post-transplant adverse events in 61 pediatric patients after hematopoietic stem cell transplantation

Cytokine serum levels during post-transplant adverse events in 61 pediatric patients after hematopoietic stem cell transplantation
11    41    1
Reduced CYP2D6 function is associated with gefitinib-induced rash in patients with non-small cell lung cancer

Reduced CYP2D6 function is associated with gefitinib-induced rash in patients with non-small cell lung cancer
9    23    1
Generalized enrichment analysis improves the detection of adverse drug events from the biomedical literature

Generalized enrichment analysis improves the detection of adverse drug events from the biomedical literature
17    40    1
Leveraging graph topology and semantic context for pharmacovigilance through twitter-streams

Leveraging graph topology and semantic context for pharmacovigilance through twitter-streams
17    52    1
Complications after non-surgical management of proximal humeral fractures: A systematic review of terms and definitions

Complications after non-surgical management of proximal humeral fractures: A systematic review of terms and definitions
7    51    1
Effect of medications on prevention of secondary osteoporotic vertebral compression fracture, non-vertebral fracture, and discontinuation due to adverse events: A meta-analysis of randomized controlled trials

Effect of medications on prevention of secondary osteoporotic vertebral compression fracture, non-vertebral fracture, and discontinuation due to adverse events: A meta-analysis of randomized controlled trials
17    50    1
Nivolumab plus ipilimumab versus nivolumab in individuals with treatmentnaive programmed death-ligand 1 positive metastatic soft tissue sarcomas: A multicentre retrospective study

Nivolumab plus ipilimumab versus nivolumab in individuals with treatmentnaive programmed death-ligand 1 positive metastatic soft tissue sarcomas: A multicentre retrospective study
8    49    1
Safety of infusing rituximab at a more rapid rate in patients with rheumatoid arthritis: Results from the RATE-RA study

Safety of infusing rituximab at a more rapid rate in patients with rheumatoid arthritis: Results from the RATE-RA study
9    30    1
Efficacy and safety of moxifloxacin in acute exacerbations of chronic bronchitis: A prospective, multicenter, observational study (AVANTI)

Efficacy and safety of moxifloxacin in acute exacerbations of chronic bronchitis: A prospective, multicenter, observational study (AVANTI)
11    35    1
A case of torsades de pointes induced by the third-generation EGFR-TKI, osimertinib combined with moxifloxacin

A case of torsades de pointes induced by the third-generation EGFR-TKI, osimertinib combined with moxifloxacin
5    33    1